ArticleNPJ precision oncology2025

Divergent oncogenic signaling and immune microenvironment changes in low-grade serous ovarian cancer patients undergoing intraperitoneal chemotherapy.

Isaac Bishara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.